Status
Conditions
About
In order to assess the risk of hepatitis B reactivation in people living with HIV and undergoing injection therapy, we propose to carry out a descriptive analysis of the evolution of hepatitis B markers in this population.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-HIV infected patients under injectable ART
Exclusion criteria
-Active HBV infection
15 participants in 1 patient group
Loading...
Central trial contact
Alissa NAQVI
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal